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With the extraordinary progress of mitochondrial science and
cell biology, novel biochemical pathways have emerged as strategic
points of bioenergetic regulation and control. They include
mitochondrial fusion, fission and organellar motility along micro-
tubules and microfilaments (mitochondrial dynamics), mitochon-
drial turnover (biogenesis and degradation), and mitochondrial
phospholipids synthesis. Yet, much is still unknown about the
mutual interaction between mitochondrial energy state, biogenesis,
dynamics and degradation. Meanwhile, clinical research into
metabolic abnormalities in tumors as diverse as renal carcinoma,
glioblastomas, paragangliomas or skin leiomyomata, has designated
new genes, oncogenes and oncometabolites involved in the
regulation of cellular and mitochondrial energy production.
Furthermore, the examination of rare neurological diseases such
as Charcot–Marie–Tooth type 2a, Autosomal Dominant Optic
Atrophy, Lethal Defect of Mitochondrial and Peroxisomal Fission,
or Spastic Paraplegia suggested involvement of MFN2, OPA1/3,
DRP1 or Paraplegin, in the auxiliary control of mitochondrial
energy production. Lastly, advances in the understanding of
mitochondrial apoptosis have suggested a supplementary role for
Bcl2 or Bax in the regulation of mitochondrial respiration and
dynamics, which has fostered the investigation of alternative
mechanisms of energy regulation. Here, we discuss the regulatory
mechanisms of cellular and mitochondrial energy production, and
we emphasize the importance of the study of rare neurological
diseases in addition to more common disorders such as cancer, for
the fundamental understanding of cellular and mitochondrial
energy production.
doi:10.1016/j.bbabio.2010.04.420
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Pink1 is mutated in some autosomal recessive forms of Parkin-
son's disease and has been linked genetically to Parkin activity and to
mitochondrial dysfunction. Recently we found that Parkin, a cytosolic
E3 ligase, translocates to mitochondria upon mitochondrial damage
or uncoupling. How Parkin may sense mitochondrial uncoupling,
however, was unknown. Pink1, a kinase located on the outer
mitochondrial membrane is strictly required for Parkin translocation
to mitochondria and for Parkin-mediated mitophagy. The mechanism
of Pink1 activation upon mitochondrial damage occurs by an
unexpected posttranslational induction process. We identified a
constitutive proteolytic processing and rapid turnover of endogenous
Pink1 leading to low basal expression on healthy mitochondria. Upon
mitochondrial uncoupling or damage, Pink1 proteolysis is prevented
leading to a dramatic upregulation of Pink1 expression on mitochon-
dria. Furthermore, Pink1 upregulation occurs selectively on individual
impaired mitochondria within a milieu of energetically functional
mitochondria in individual cells. We thus identify a novel mechanism
for detection of mitochondrial function in cells and propose that
lesions in a mitochondrial quality control pathway may contribute to
some forms of parkinsonism.
doi:10.1016/j.bbabio.2010.04.421
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Mitochondrial morphology is regulated by the balanced processes
of fission and fusion; whether these events play a role also in shaping
cell functions is still not well understood. Here we provide evidence
that during myogenic differentiation the short mitochondria of
myoblasts change into the extensively elongated network observed
in myotubes. We show that mitochondrial elongation is required for
myogenesis to occur and that this event depends on the cellular
generation of nitric oxide (NO). Inhibition of NO synthesis inmyogenic
precursor cells leads to inhibition of mitochondrial elongation and of
myogenic differentiation. The specific target of NO action is Drp1. NO
controls Drp1 translocation to mitochondria and its docking to the
specific interactor Fis1; further, it controls the GTPase activity of the
protein. In the presence of NO Drp1 functions are maintained at basal
levels to allow mitochondria to create a fused network that enhances
myogenic differentiation. The action of NO on Drp1 is mediated
through a direct phosphorylation of the protein, induced by activation
of PKG. Inhibition of the NO pathway leads to mitochondrial fission
accounting for a latent mitochondrial dysfunction, reducing respira-
tory activity and OXPHOS ATP production. Despite the apoptotic
features of these mitochondria, myoblasts do not undergo sponta-
neous apoptosis. They acquire sensitivity to apoptosis in the presence
of 3-methyl-adenine, a general inhibitor of lysosomes degradation. In
additionwe found a decrease ofmitochondrial number and DNAwhen
NOgenerationwas inhibited, accompanied by increases in LC3 positive
autophagosomes and cleavage of LC3. These findings suggest that
mitochondrial latent dysfunction is related to induction of a mitopha-
gic prosurvival pathway. In this study we demonstrate a new
regulation of Drp1 function mediated by NO and the fundamental
role played by this regulation during myogenic differentiation. In
addition we show how mitophagy can act as a protective factor in the
absence of NO. These results unravel a fine control check of the
myogenic differentiation programme dependent on metabolic signals.
doi:10.1016/j.bbabio.2010.04.422
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